Clinical Trial Update: Temozolomide in Treating Women With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update concerns the Phase 2 evaluation of temozolomide for women with advanced breast cancer. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN